Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials - Brun, MK; Gehin, JE; Bjørlykke, KH (Lancet Rheumatol, 2024)